Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2009, p. 3972-3980, Vol. 53, No. 9
0066-4804/09/$08.00+0 doi:10.1128/AAC.00723-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
,
Department of Chemistry, Brown University, 324 Brook Street, Providence, Rhode Island 02912
Received 28 May 2009/ Accepted 12 June 2009
Indolmycin, a potential antibacterial drug, competitively inhibits bacterial tryptophanyl-tRNA synthetases. An effort to identify indolmycin resistance genes led to the discovery of a gene encoding an indolmycin-resistant isoform of tryptophanyl-tRNA synthetase. Overexpression of this gene in an indolmycin-sensitive strain increased the indolmycin MIC 60-fold. Its transcription and distribution in various bacterial genera were assessed. The level of resistance conferred by this gene was compared to that of a known indolmycin resistance gene and to those of genes with resistance-conferring point mutations.
Published ahead of print on 22 June 2009.
Supplemental material for this article may be found at http://aac.asm.org/.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»